Treating erectile dysfunction by endothelial rehabilitation with phosphodiesterase 5 inhibitors
Author:
Publisher
Springer Science and Business Media LLC
Subject
Urology
Link
http://link.springer.com/content/pdf/10.1007/s00345-005-0021-7.pdf
Reference31 articles.
1. Verma S, Buchanan MR, Anderson TJ (2003) Endothelial function as a biomarker of vascular disease. Circulation 108:2054–2059
2. Kloner RA, Speakman M (2002) Erectile dysfunction and atherosclerosis. Curr Atheroscler Rep 4:397–401
3. Soloman H, Man JW, Jackson G (2003) Erectile dysfunction and the cardiovascular patient: endothelial dysfunction is the common denominator. Heart 89:251–254
4. Rosen MP, Greenfield AJ, Walker TG, et al (1991) Cigarette smoking: an independent risk factor for atherosclerosis in the hypogastric-cavernous arterial bed of men with atherogenic impotence. J Urol 145:759–763
5. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, Mc Kinlay JB (1994) Impotence and its medical and psychological correlates: results of the Massachusetts Male Aging Study. J Urol 151:54–61
Cited by 44 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Grapefruit peel extract mitigates paroxetine‐induced erectile dysfunction in rats through stimulation of erectile response, antioxidant status, and inhibition of key enzymes related with impaired penile erection;Journal of Food Biochemistry;2022-04-23
2. Alkaloids-rich extracts from Cannabis sativa, Datura stramonium, and Nicotiana tabacum modulate sexual behavior and key enzymes relevant to sexual function in rats;Comparative Clinical Pathology;2022-03-23
3. MANAGEMENT OF ERECTILE DYSFUNCTION IN CARDIOVASCULAR PATIENTS WITH COMORBIDITIES: REVIEW OF THE TRIALS ON CONTINUING THERAPY WITH PHOSPHODIESTERASE-5 MEDICATIONS;Cardiovascular Therapy and Prevention;2018-06-20
4. Quercetin, rutin, and their combinations modulate penile phosphodiesterase-5′, arginase, acetylcholinesterase, and angiotensin-I-converting enzyme activities: a comparative study;Comparative Clinical Pathology;2018-02-13
5. Novel Therapeutic Targets for Phosphodiesterase 5 Inhibitors: current state-of-the-art on systemic arterial hypertension and atherosclerosis;Current Pharmaceutical Biotechnology;2016-02-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3